Researchers from the University of Chicago and the University of Southern California sought to determine how much the U.S. and 10 European countries spent on cancer care and what outcomes were associated with those healthcare costs. Their analysis showed that while U.S. spending increased dramatically (49 percent) faster than Europe (16 percent) from 1983 to 1999, U.S. patient also saw longer average survival times (11.1 years) than Europe (9.3 years).
The authors did note the study may be limited due to reliance on older data. They suggest further research may help better understand the value of increased healthcare spending on cancer care.
Related Articles on Cancer Care:
Patients Test Negative for Blood Infections From Poor Quality at Shuttered Cancer Center
Long Island Jewish Medical Center in New York Opens New Cardiovascular Unit
Price Tags of Preventive Services Costs Could Vary Up to 755%
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
